Jane Street
AUPH icon

Jane Street’s Aurinia Pharmaceuticals AUPH Stock Holding History

Jane Street’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
62,700
+43,200
+222% +$690K ﹤0.01% 6419
2026
Q1 		$289K Sell
19,500
-126,600
-87% -$1.85M ﹤0.01% 9316
2025
Q4 		$2.33M Sell
146,100
-1,700
-1% -$24.1K ﹤0.01% 4510
2025
Q3 		$1.63M Buy
147,800
+24,900
+20% +$272K ﹤0.01% 5311
2025
Q2 		$1.04M Sell
122,900
-3,700
-3% -$29.7K ﹤0.01% 5542
2025
Q1 		$1.02M Sell
126,600
-99,100
-44% -$803K ﹤0.01% 5537
2024
Q4 		$2.03M Buy
225,700
+66,900
+42% +$546K ﹤0.01% 4077
2024
Q3 		$1.16M Buy
158,800
+600
+0.4% +$3.72K ﹤0.01% 5590
2024
Q2 		$903K Sell
158,200
-17,900
-10% -$94.3K ﹤0.01% 5955
2024
Q1 		$882K Buy
176,100
+134,900
+327% +$915K ﹤0.01% 5635
2023
Q4 		$370K Sell
41,200
-41,000
-50% -$338K ﹤0.01% 7291
2023
Q3 		$639K Sell
82,200
-193,800
-70% -$1.9M ﹤0.01% 5886
2023
Q2 		$2.67M Buy
276,000
+184,900
+203% +$1.92M ﹤0.01% 3694
2023
Q1 		$998K Buy
91,100
+72,800
+398% +$641K ﹤0.01% 4997
2022
Q4 		$79.1K Sell
18,300
-215,500
-92% -$1.25M ﹤0.01% 8217
2022
Q3 		$1.76M Buy
233,800
+50,200
+27% +$435K ﹤0.01% 4412
2022
Q2 		$1.84M Sell
183,600
-212,700
-54% -$2.38M ﹤0.01% 4322
2022
Q1 		$4.91M Sell
396,300
-103,800
-21% -$1.6M ﹤0.01% 3057
2021
Q4 		$11.4M Sell
500,100
-75,800
-13% -$1.8M ﹤0.01% 1722
2021
Q3 		$12.7M Buy
575,900
+197,700
+52% +$3.14M ﹤0.01% 1502
2021
Q2 		$4.9M Buy
378,200
+350,500
+1,265% +$4.46M ﹤0.01% 2669
2021
Q1 		$360K Sell
27,700
-174,000
-86% -$2.52M ﹤0.01% 7396
2020
Q4 		$2.79M Buy
201,700
+158,400
+366% +$2.31M ﹤0.01% 2918
2020
Q3 		$638K Sell
43,300
-15,400
-26% -$223K ﹤0.01% 4781
2020
Q2 		$954K Buy
58,700
+47,100
+406% +$754K ﹤0.01% 4130
2020
Q1 		$168K Sell
11,600
-23,800
-67% -$420K ﹤0.01% 4725
2019
Q4 		$717K Buy
+35,400
New +$326K ﹤0.01% 3227

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street's AUPH Position: Q2 2026 in Review

Jane Street reduced its Aurinia Pharmaceuticals (AUPH) stake by 92% in Q2 2026, selling an estimated $6.64M and leaving 36,598 shares worth $621K. The position accounts for ﹤0.01% of the portfolio, ranked #7517.

Jane Street first reported a position in AUPH in Q1 2017 and has held it in 29 quarters since. The position peaked at $14.5M in Q4 2025. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Jane Street held 36,598 shares of Aurinia Pharmaceuticals worth $621K as of Q2 2026.
  • Jane Street sold 415,506 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $6.64M.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7517 holding.
  • Jane Street first reported a position in Aurinia Pharmaceuticals in Q1 2017 and has held it in 29 quarters since.
  • Jane Street's Aurinia Pharmaceuticals position peaked at $14.5M in Q4 2025.
  • 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.